Articles scientifiques

Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis.

Auteurs : Azim HA, Singhal S, Ignatiadis M, Desmedt C, Fumagalli D, Veys I, Larsimont D, Piccart-Gebhart M, Michiels S, Sotiriou C
Année : 2013
Journal : PLoS One
Volume : 8(4)
Pages : e62451

Emerging targeted agents in metastatic breast cancer.

Auteurs : Zardavas D, Baselga J, Piccart-Gebhart M
Année : 2013
Journal : Nat Rev Clin Oncol
Volume : 10(4)
Pages : 191-210

Metasin-An Intra-Operative RT-qPCR Assay to Detect Metastatic Breast Cancer in Sentinel Lymph Nodes.

Auteurs : Al-Ramadhani S, Sai-Giridhar P, George D, Gopinath P, Arkoumani E, Jader S, Sundaresan M, Salgado R, Larsimont D, Bustin SA, Sundaresan V
Année : 2013
Journal : Int J Mol Sci
Volume : 14(7)
Pages : 12931-52

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.

Auteurs : Bertucci F, Finetti P, Roche H, Le Doussal JM, Marisa L, Martin AL, Lacroix-Triki M, Blanc-Fournier C, Jacquemier J, Peyro-Saint-Paul H, Viens P, Sotiriou C, Birnbaum D, Penault-Llorca F
Année : 2013
Journal : Ann Oncol
Volume : 24(3)
Pages : 625-32

A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer.

Auteurs : Martin M, Bonneterre J, Geyer CE, Ito Y, Ro J, Lang I, Kim SB, Germa C, Vermette J, Wang K, Awada A
Année : 2013
Journal : Eur. J. Cancer
Volume : 49(18)
Pages : 3763-72

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.

Auteurs : Peeters DJ, De Laere B, Van den Eynden GG, Van Laere SJ, Rothé F, Ignatiadis M, Sieuwerts AM, Lambrechts D, Rutten A, van Dam PA, Pauwels P, Peeters M, Vermeulen PB, Dirix LY
Année : 2013
Journal : Br J Cancer
Volume : 108(6)
Pages : 1358-67

Is it possible to improve the breaking bad news skills of residents when a relative is present? A randomised study.

Auteurs : Merckaert I, Liénard A, Libert Y, Bragard I, Delvaux N, Etienne AM, Marchal S, Meunier J, Reynaert C, Slachmuylder JL, Razavi D
Année : 2013
Journal : Br J Cancer
Volume : 109(10)
Pages : 2507-14

Change in the microenvironment of breast cancer studied by FTIR imaging.

Auteurs : Kumar S, Desmedt C, Larsimont D, Sotiriou C, Goormaghtigh E
Année : 2013
Journal : Analyst
Volume : 138(14)
Pages : 4058-65

Personalized therapy for breast cancer: a dream or a reality?

Auteurs : Zardavas D, Pugliano L, Piccart-Gebhart M
Année : 2013
Journal : Future Oncol
Volume : 9(8)
Pages : 1105-19

Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer.

Auteurs : Loi S, Michiels S, Lambrechts D, Fumagalli D, Claes B, Kellokumpu-Lehtinen PL, Bono P, Kataja V, Piccart-Gebhart M, Joensuu H, Sotiriou C
Année : 2013
Journal : J. Natl. Cancer Inst.
Volume : 105(13)
Pages : 960-967

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.

Auteurs : Bianchini G, Pusztai L, Karn T, Iwamoto T, Rody A, Kelly CM, Müller V, Schmidt M, Qi Y, Holtrich U, Becker S, Santarpia L, Fasolo A, Del Conte G, Zambetti M, Sotiriou C, Haibe-Kains B, Symmans WF, Gianni L
Année : 2013
Journal : Breast Cancer Res
Volume : 15(5)
Pages : R86

Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embedding.

Auteurs : Verdonck M, Wald N, Janssis J, Yan P, Meyer C, Legat A, Speiser DE, Desmedt C, Larsimont D, Sotiriou C, Goormaghtigh E
Année : 2013
Journal : Analyst
Volume : 138(14)
Pages : 4083-91

Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 study.

Auteurs : Campone M, Bachelot T, Gnant M, Deleu I, Rugo HS, Pistilli B, Noguchi S, Shtivelband M, Pritchard KI, Provencher L, Burris HA, Hart L, Melichar B, Hortobagyi GN, Arena F, Baselga J, Panneerselvam A, Héniquez A, El-Hashimyt M, Taran T, Sahmoud T, Piccart-Gebhart M
Année : 2013
Journal : Eur. J. Cancer
Volume : 49(12)
Pages : 2621-32

Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.

Auteurs : Metzger-Filho O, Catteau A, Michiels S, Buyse M, Ignatiadis M, Saini KS, de Azambuja E, Fasolo V, Naji S, Canon JL, Delrée P, Coibion M, Cusumano P, Jossa V, Kains JP, Larsimont D, Richard V, Faverly D, Cornez N, Vuylsteke P, Vanderschueren B, Peyro-Saint-Paul H, Piccart-Gebhart M, Sotiriou C
Année : 2013
Journal : PLoS One
Volume : 8(8)
Pages : e66848

Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer.

Auteurs : Andre F, Dieci MV, Dubsky P, Sotiriou C, Curigliano G, Denkert C, Loi S
Année : 2013
Journal : Clin Cancer Res
Volume : 19(1)
Pages : 28-33

Luminal breast cancer: from biology to treatment.

Auteurs : Ignatiadis M, Sotiriou C
Année : 2013
Journal : Nat Rev Clin Oncol
Volume : 10(9)
Pages : 494-506

Evaluation of the effect of computer-aided classification of benign and malignant lesions on reader performance in automated three-dimensional breast ultrasound.

Auteurs : Tan T, Platel B, Twellmann T, van Schie G, Mus R, Grivegnée A, Mann RM, Karssemeijer N
Année : 2013
Journal : Acad Radiol
Volume : 20(11)
Pages : 1381-8

Planning cancer control in Latin America and the Caribbean.

Auteurs : Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, Louis JS, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G
Année : 2013
Journal : Lancet Oncol
Volume : 14(5)
Pages : 391-436

Personalised cancer management: closer, but not here yet.

Auteurs : Piccart-Gebhart M
Année : 2013
Journal : Ann Oncol
Volume : 24(8)
Pages : 1951-5

How Long is Enough - Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast Cancer.

Auteurs : Pinto AC, de Azambuja E, Piccart-Gebhart M
Année : 2013
Journal : Breast Care (Basel)
Volume : 8(4)
Pages : 264-269